Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

PNNL is lending analytics expertise to a new first-of-its-kind electric-vehicle carsharing program being launched in Hood River, Oregon.

A webapp developed by PNNL in collaboration with the University of Washington to help drive efficiencies for urban delivery drivers is now in the prototype stage and ready for testing.

Using public data from the entire 1,500-square-mile Los Angeles metropolitan area, PNNL researchers reduced the time needed to create a traffic congestion model by an order of magnitude, from hours to minutes.

Researchers at PNNL are contributing artificial intelligence, machine learning, and app development expertise to a U of W project that will ease challenges with urban freight delivery. The project will provide delivery drivers with a tool

PNNL wins seven R&D 100 awards – total tops 100